Daiichi Sankyo Announces Approval of Silodosin in China; Aims for Launch in 2012

September 26, 2011
Daiichi Sankyo announced on September 14 that its Chinese subsidiary Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd. received approval from China’s State Food and Drug Administration (SFDA) on August 25 for silodosin (brand name in Japan: Urief) for the treatment of...read more